Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure.
von Haehling S, Filippatos GS, Papassotiriou J, Cicoira M, Jankowska EA, Doehner W, Rozentryt P, Vassanelli C, Struck J, Banasiak W, Ponikowski P, Kremastinos D, Bergmann A, Morgenthaler NG, Anker SD. von Haehling S, et al. Among authors: morgenthaler ng. Eur J Heart Fail. 2010 May;12(5):484-91. doi: 10.1093/eurjhf/hfq031. Epub 2010 Mar 9. Eur J Heart Fail. 2010. PMID: 20215339 Free article.
Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial.
Möckel M, Searle J, Hartmann O, Anker SD, Peacock WF, Wu AH, Maisel A; BACH Writing group; Slagman A, Vollert JO, Papassotiriou J, Anand I, Christenson R, Daniels LB, Filippatos GS, Hogan C, Morgenthaler N, Mueller C, Neath SX, Ng L, Nowak R, Richards M, Di Somma S, Ponikowski P. Möckel M, et al. Among authors: ng l, morgenthaler n. Emerg Med J. 2013 Aug;30(8):633-7. doi: 10.1136/emermed-2012-201530. Epub 2012 Sep 9. Emerg Med J. 2013. PMID: 22962091 Clinical Trial.
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD. von Haehling S, et al. Among authors: morgenthaler ng. J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. doi: 10.1016/j.jacc.2007.08.012. Epub 2007 Oct 29. J Am Coll Cardiol. 2007. PMID: 17996563 Free article.
Short-term mortality risk in emergency department acute heart failure.
Peacock WF, Nowak R, Christenson R, DiSomma S, Neath SX, Hartmann O, Mueller C, Ponikowski P, Möckel M, Hogan C, Wu AH, Richards M, Filippatos GS, Anand I, Ng LL, Daniels LB, Morgenthaler N, Anker SD, Maisel AS. Peacock WF, et al. Among authors: ng ll, morgenthaler n. Acad Emerg Med. 2011 Sep;18(9):947-58. doi: 10.1111/j.1553-2712.2011.01150.x. Acad Emerg Med. 2011. PMID: 21906204 Free article.
Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T. Gegenhuber A, et al. Among authors: morgenthaler ng. J Card Fail. 2007 Feb;13(1):42-9. doi: 10.1016/j.cardfail.2006.09.004. J Card Fail. 2007. PMID: 17339002
Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R. Neuhold S, et al. Among authors: morgenthaler ng. J Am Coll Cardiol. 2008 Jul 22;52(4):266-72. doi: 10.1016/j.jacc.2008.03.050. J Am Coll Cardiol. 2008. PMID: 18634981 Free article.
201 results